Enzyme may hold key to a form of blindness
10
2005
Researchers led by Gabriel Travis, a University of California (Los Angeles), biochemist, said that scientists previously were unable to explain the chemistry behind the known link between a gene known as Rpe65 and Leber.<br><br>“This suggests that replacement of Rpe65 by gene therapy should correct the blindness in these children, as was observed in mice and dogs with Rpe65 mutations,” said Travis.<br><br>Trials of the cure in humans may start before the end of next year, under the supervision of Samuel Jacobson, a University of Pennsylvania ophthalmologist. The new findings were published in the journal ‘Cell’.
Bloomberg News
Jeffrey Tannenbaum
I